In recognition of Lung Cancer Awareness Month, we highlight a recent study in JAMA Oncology that found RET fusion-positive NSCLC tumors express membrane targets that could provide potential avenues for novel therapies. The study used Caris’ whole transcriptome sequencing data from >19,700 lung cancer patients to confirm target expression. https://ow.ly/fAk950XrWUp #LungCancerAwareness